Lipocine Inc (LPCN)
4.455
-0.34
(-7.19%)
USD |
NASDAQ |
Apr 24, 16:00
4.455
0.00 (0.00%)
After-Hours: 17:25
Lipocine Cash from Financing (TTM): 0.4046M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.4046M |
September 30, 2023 | 0.404M |
June 30, 2023 | -0.0171M |
March 31, 2023 | -1.506M |
December 31, 2022 | -2.127M |
September 30, 2022 | -2.960M |
June 30, 2022 | -3.798M |
March 31, 2022 | -3.143M |
December 31, 2021 | 26.92M |
September 30, 2021 | 32.32M |
June 30, 2021 | 37.82M |
March 31, 2021 | 45.46M |
December 31, 2020 | 20.90M |
September 30, 2020 | 22.16M |
June 30, 2020 | 17.32M |
March 31, 2020 | 9.969M |
December 31, 2019 | 10.32M |
September 30, 2019 | 5.066M |
June 30, 2019 | 5.330M |
March 31, 2019 | 5.882M |
December 31, 2018 | 10.65M |
September 30, 2018 | 10.14M |
June 30, 2018 | 12.43M |
Date | Value |
---|---|
March 31, 2018 | 18.14M |
December 31, 2017 | 11.23M |
September 30, 2017 | 11.75M |
June 30, 2017 | 9.367M |
March 31, 2017 | 3.658M |
December 31, 2016 | 0.6059M |
September 30, 2016 | 0.0342M |
June 30, 2016 | 0.0918M |
March 31, 2016 | 32.61M |
December 31, 2015 | 32.72M |
September 30, 2015 | 32.72M |
June 30, 2015 | 32.66M |
March 31, 2015 | 0.1529M |
December 31, 2014 | -0.2551M |
September 30, 2014 | 12.28M |
June 30, 2014 | 48.22M |
March 31, 2014 | 48.21M |
December 31, 2013 | 48.48M |
September 30, 2013 | 35.98M |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.0405M |
December 31, 2012 | 0.0405M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.798M
Minimum
Jun 2022
45.46M
Maximum
Mar 2021
11.62M
Average
5.330M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
Alpine Immune Sciences Inc | 165.12M |
Eliem Therapeutics Inc | 0.841M |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |